Cannabis in Australia

Cannabis in Australia

Australian regulations allow cannabis products for medicinal and research purposes only. Medical cannabis continues to gain momentum in the country, driven by growing number of legal patients. As local production increases, more companies enter, prices fall, and patients increase usage. In December 2020, low-dose CBD products were down scheduled to enable sale over the counter. However, we are likely to see the first product by early 2023 as manufacturers still need to register their products on...

Euromonitor International's Cannabis in Australia market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2025 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.